JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Search results for: 'bay 59 3074'

Search results for: 'bay 59 3074'

A4210 Bay 11-7821 (BAY 11-7082)
1 Citation

Summary: IKK/NF-κB/TNFα inhibitor

insoluble in H2O; ≥64 mg/mL
A8550 Telatinib (BAY 57-9352)

Target: VEGFR|PDGFR|c-Kit

Summary: VEGFR-2/-3,PDGFR-β and c-Kit inhibitor

insoluble in H2O; insoluble in EtOH; ≥20.5 mg/mL
B3033 Bay 11-7085
1 Citation

Summary: NK-κB activation inhibitor

≥12.45 mg/mL
B5612 BAY 60-6583

Target: Adenosine A2B Receptors

Summary: Potent A2B receptor agonist

≥36.1 mg/mL
C3639 BAY 41-8543

Summary: heme-dependent stimulator of soluble guanylate cyclase (sGC)

≤3 mg/mL
C3753 BAY u3405

Summary: DP2 receptor antagonist

≤30 mg/mL
B5309 Bay 36-7620

Summary: Selective mGlu1 receptor non-competitive antagonist

<27.84 mg/mL
B5329 Bay 55-9837

Summary: Selective VPAC2 receptor agonist

Soluble to 2 mg/mL
B7664 BAY 41-2272

Summary: Activator of soluble guanylyl cyclase (sGC)

Soluble in DMSO
B1029 BAY 57-1293

Target: HSV

Summary: HSV helicase-primase inhibitor

insoluble in H2O; insoluble in EtOH; ≥13.9 mg/mL